We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
iQIYI
IQ
$1.28B
| $228K | ﹤0.01% |
84,031
| – | – |
|
1152
Brink's
BCO
$4.69B
| $227K | ﹤0.01% |
4,677
+1,200
| +35% | +$66.8K |
|
1153
Parker-Hannifin
PH
$135B
| $224K | ﹤0.01% |
923
-24,309
| -96% | -$6.58M |
|
1154
Relmada Therapeutics
RLMD
$503M
| $224K | ﹤0.01% |
+6,051
| New | +$168K |
|
|
MPX
1155
DELISTED
Marine Products Corp
MPX
| $221K | ﹤0.01% |
26,132
+256
| +1% | +$2.57K |
|
1156
Chesapeake Utilities
CPK
$3.25B
| $218K | ﹤0.01% |
1,889
| – | – |
|
1157
Devon Energy
DVN
$49.3B
| $218K | ﹤0.01% |
3,626
-2,993
| -45% | -$186K |
|
1158
Dow Inc
DOW
$22.1B
| $217K | ﹤0.01% |
4,939
-661,617
| -99% | -$33.5M |
|
1159
DraftKings
DKNG
$12.7B
| $214K | ﹤0.01% |
+14,104
| New | +$224K |
|
1160
Hartford Financial Services
HIG
$37.7B
| $213K | ﹤0.01% |
+3,433
| New | +$223K |
|
|
TMHC
1161
DELISTED
Taylor Morrison
TMHC
| $213K | ﹤0.01% |
9,146
-6,662
| -42% | -$173K |
|
1162
Jackson Financial
JXN
$8.85B
| $212K | ﹤0.01% |
+7,643
| New | +$226K |
|
1163
Cousins Properties
CUZ
$4.85B
| $211K | ﹤0.01% |
9,057
-87,392
| -91% | -$2.47M |
|
1164
International Bancshares
IBOC
$4.52B
| $211K | ﹤0.01% |
+4,955
| New | +$211K |
|
1165
Citi Trends
CTRN
$617M
| $210K | ﹤0.01% |
13,560
+4,460
| +49% | +$105K |
|
1166
Palantir
PLTR
$411B
| $206K | ﹤0.01% |
25,280
-32,655
| -56% | -$290K |
|
1167
Nasdaq
NDAQ
$53.5B
| $205K | ﹤0.01% |
+3,612
| New | +$212K |
|
|
DCPH
1168
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $203K | ﹤0.01% |
10,970
| – | – |
|
1169
Rivian
RIVN
$23.1B
| $202K | ﹤0.01% |
6,153
-30,577
| -83% | -$1.04M |
|
1170
Roper Technologies
ROP
$39.1B
| $202K | ﹤0.01% |
563
-359
| -39% | -$146K |
|
|
TRTN
1171
DELISTED
Triton International Limited
TRTN
| $202K | ﹤0.01% |
3,695
-18,650
| -83% | -$1.12M |
|
1172
Freeport-McMoran
FCX
$96.9B
| $201K | ﹤0.01% |
7,354
-50,537
| -87% | -$1.48M |
|
1173
Planet Fitness
PLNT
$3.65B
| $201K | ﹤0.01% |
3,487
| – | – |
|
|
EXPR
1174
DELISTED
Express, Inc.
EXPR
| $199K | ﹤0.01% |
+9,112
| New | +$311K |
|
|
RNAM
1175
DELISTED
Avidity Biosciences
RNAM
| $196K | ﹤0.01% |
12,025
-5,670
| -32% | -$108K |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.